Sejong Medical세종메디칼
258830 · KOSDAQ · ₩258830 · 세종메디칼
₩412 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 58.5% | 57.3% | 54.9% | 51.4% | 50.9% | 52.5% |
| Operating margin | 23.2% | 14.2% | 6.8% | 16.2% | −11.2% | −4.5% |
| Net margin | 13.3% | 3.0% | −376.3% | −101.4% | −605.9% | −19.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +4.1% | +7.9% | −2.4% | +8.5% | +7.0% | — |
| Operating income growth | +69.5% | +124.5% | −58.9% | +257.2% | −166.1% | — |
| Net income growth | +362.9% | +100.9% | −262.3% | +81.8% | −3,150.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 9.8% | 2.2% | −360.4% | −92.9% | −238.0% | −5.4% |
| Return on assets | 4.5% | 1.1% | −83.3% | −14.4% | −85.1% | −3.3% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 129.7% | 110.0% | 89.4% | 786.0% | 418.2% | 64.2% |
| Net debt to equity | −21.4% | −8.9% | 29.3% | 567.6% | 176.9% | −14.4% |
| Current ratio | 298.8% | 70.5% | 220.1% | 14.1% | 37.7% | 767.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Sejong Medical / 세종메디칼 / 258830 / KRX:258830
Source: KRX statistical information